MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer. (Q40868446)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

Daniel Vilarim Araújo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

Aldo Lourenço Abbade Dettino

10 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

Ludmilla Thomé Domingos Chinen

10 March 2020

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Emne Ali Abdallah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marcello Ferretti Fanelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Virgílio Souza E Silva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marcelo Calil Machado Netto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

José Luiz Gasparini Junior

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Luciana Menezes Mendonça Ocea

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marcilei Eliza Cavicchioli Buim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Milena Shizue Tariki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Vanessa da Silva Alves

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Victor Piana de Andrade

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Celso Abdon Lopes de Mello

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

28 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

890-898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

10 March 2020

cites work

1 reference

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

21 January 2018

1 reference

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

21 January 2018

1 reference

The MRP family and anticancer drug metabolism

21 January 2018

1 reference

Role of the MRP1/ABCC1 multidrug transporter protein in cancer

21 January 2018

1 reference

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

Towards a knowledge-based Human Protein Atlas

21 January 2018

1 reference

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

21 January 2018

1 reference

The role of ABC transporters in progression and clinical outcome of colorectal cancer.

21 January 2018

1 reference

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

21 January 2018

1 reference

ABC transporters as differentiation markers in glioblastoma cells

21 January 2018

1 reference

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

Therapeutic strategy in unresectable metastatic colorectal cancer.

21 January 2018

1 reference

How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment

21 January 2018

1 reference

Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients

21 January 2018

1 reference

Decreased functional activity of multidrug resistance protein in primary colorectal cancer

21 January 2018

1 reference

Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

21 January 2018

1 reference

Mrp4 confers resistance to topotecan and protects the brain from chemotherapy

21 January 2018

1 reference

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer

21 January 2018

1 reference

Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

21 January 2018

1 reference

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma

21 January 2018

1 reference

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion

21 January 2018

1 reference

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950035%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference